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INTRODUCTION 
Globally, an estimated 3.3 billion people in 97 coun-
tries are at risk of being infected with malaria of 
which 1.2 billion face a high risk. The disease 
caused 584 000 deaths in 2013 alone. The burden is 
high particularly in the African region where 90% 
of all malaria deaths occur and in the children aged 
less than 5 years who account for 78% of all deaths.1 
The disease has been estimated to cost the continent 
more than US$12 billion every year in lost Gross 
Domestic Product and an average loss of 1.3% of 
economic growth per year. Up to 40% of the con-
tinent’s health budget is spent on this disease every 
year. On average, malaria stricken family loses a 
quarter of its income through loss of earnings and 
the cost of treating and preventing the disease.2 In 
Ethiopia, P. falciparum and P. vivax contribute to 
malaria morbidity in the nation in relative propor-
tions of 60% and 40% respectively. Approximately 
52 million people (68%) live in malaria risk areas3 
and over 5 million episodes of malaria occur each 
year in the nation.4 
Management of malaria has been challenged by 
several factors including resistance development 
against the drugs. P.falciparum has already become 
less sensitive to antimalarial drugs such as chloro-
quine, and sulphadoxine pyrimethamine and there 
are also reports on resistance to currently existing 
first line drug regimen ACT in parts of Cambodia, 
Thailand as well as reduced sensitivity in parts of 
Africa.5 Therefore, new knowledge, products and 
measures and in particular new chemotherapeutic 
tools are urgently needed. Particularly plants have 
been an important source of drugs. As high as 25% 
of the drugs prescribed worldwide were derived 
from plants and of the drugs considered as basic 
and essential by the World Health Organization 
(WHO), 11% are exclusively of plant origin or syn-
thetic drugs obtained from natural precursors.6
Majority of antimalarial drugs have been derived 
from medicinal plants or from structures modeled 
on plant derived compounds. These include the 
quinoline-based antimalarials as well as artemisinin 
and its derivatives.7 Worldwide, over 1,200  plant 
species are reportedly used for the treatment of 
malaria and fever and thus are potential sources of 
new anti-malarial treatments.8 
Ruta chalepensis L (Family: Rutaceae), locally 
known as tenadam, is an erect perennial herb, 
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becoming woody at base, and grows up to 1.5 m 
height. Stems branched at all heights with light-
green to blue-green color.9 It is one of the most fre-
quently used plants for medicinal purposes. It has 
been used by the local community as traditional 
remedy against fever, headache, and common 
cold and as an insect repellant.10,12 It is also used 
as food flavoring, against rheumatism, mental 
disorders, dropsy, neuralgia, menstrual problems, 
convulsions, and other bleeding and nervous 
disorders in different parts of the world.13 An eth-
nobotanic investigation conducted in Yemeni in 
2009 documented an antimalarial use of this plant 
in such a way that 8-10 fresh leaves are chewed 
without swallowing twice a day for 5 days.14 There 
is also undocumented use of the plant in malaria 
management by the local people in Ethiopia. 
Several studies reported that R.chalepensis is a 
rich source of important secondary metabolites 
such as alkaloids, flavonoids, phenols, amino 
acids, furanocoumarins, saponins, volatile oil, 
glycosides, sterols and triterpenes.15,16 Analgesic, 
antipyretic, antioxidant, antiinflamatory, anti-
convulsant, and anxiolytic effects are confirmed 
experimentally.16,17 
In Ethiopia, medicinal plants have been com-
monly used for treatment of several diseases includ-
ing malaria. It has been frequently described that 
more than 80% of the population have been using 
traditional medicine.18 Therefore efficacy and safety 
of traditionally used remedies need to be evaluated 
and this study was carried out as a move to accom-
plish this objective.
RESEARCH DESIGN AND METHODS
Plant material
Fresh aerial parts of R.chalepensis, locally called 
tenadam, were collected in April 2013 from 
Gondar, Northwest Ethiopia. The plant specimen 
was identified and authenticated at the National 
Herbarium, Department of Biology, Addis Ababa 
University where a specimen was deposited with a 
voucher number of A001.
Preparation of plant extract
The leaves were collected, cleaned, shade dried at 
room temperature for about three weeks, crushed 
into coarse power using mortar and pestle, weighed 
using electronic balance and placed in plastic bags 
until extraction. Four hundred and thirty gram 
of the powdered plant was macerated using 80% 
methanol for 72 hr with occasional stirring. Then, 
the filtrate was separated from the mark using 
Whatman filter paper (Grade 1) and the mark was 
re-macerated further two times. The filtrates were 
combined, dried in an oven (Leaders Engineering, 
UK) at a temperature not exceeding 40οC, and 
stored at 4°C using air-tight container until further 
use. For the various experiments conducted, the 
extract was reconstituted in distilled water at appro-
priate concentrations. 
Experimental animals
Adult Swiss albino mice of female sex weighing 
20-25g and aged 6-8 weeks were obtained from 
Ethiopian Health and Nutritional Research Institute 
(EHNRI). The animals were housed in a stan-
dard polyethylene glycol cage. They were fed with 
standard diet and water ad libitum, and allowed a 
one-week acclimatization period prior to the study. 
The animals were maintained under standard con-
ditions of humidity, temperature and 12h light/12h 
darkness cycle. This experiment was conducted in 
accordance with the internationally accepted labo-
ratory animal care and use guideline.19 
Parasite: Chloroquine sensitive Plasmodium ber-
ghei ANKA strain was obtained from EHNRI and 
was subsequently maintained in the laboratory 
by serial blood passage from mouse to mouse on 
weekly bases. 
Phytochemical tests: The 80% methanol leaf extract 
of R.chalepensis was subjected to qualitative phyto-
chemical screening (for the presence of alkaloid, 
flavonoid, polyphenols, terpenoids, cardiac gly-
cosides as well as saponins) according to standard 
methods.20,21
Test for alkaloids: Thoroughly ground material 
(2 g) was treated in a test tube with 10 ml of 1% 
HCl for 30 min in a water bath. The suspension 
was filtered through cotton into test tube and was 
divided into two parts and to one part of the solu-
tion five drops of Dragendorff‟s reagent and to 
the other part five drops of Mayer‟s reagent were 
added. If the alkaloids are present the test with 
Dragendorff‟s reagent should form a yellowish 
orange precipitate or a whitish opalescence with 
Mayer‟s reagent.
Test for saponins: An aliquot of the extract in a 
15 ml test tube was vigorously shaken for 2 min. The 
frothing which persists for 15 min was inspected 
for indication of the presence of saponins in the 
extracts. 
Test for Phenols: A mixture of one ml 1% FeCl3 
and one ml of 1% K3Fe(CN)6 was prepared imme-
diately before this test. Then, to two ml of filtered 
solution of the aqueous macerate of plant material, 
www.phytomedicine.ejournals.ca Discovery Phytomedicine 2017; 4 (1): 1-7. doi: 10.15562/phytomedicine.2017.37 3
In vivo antiplasmodial activity ... Dessalegn Asmelashe Gelayee et al.
three drops of a mixture of 1% FeCl3 and 1% K3 
Fe(CN)6 were added. The final solution should 
form a green blue colour if it contains phenolic 
compounds. 
Test for flavonoids: The dried 80% methanolic 
extract(100 mg)was dissolved in a mixture of meth-
anol and water. To 2 ml of the extract solution, 
three to five drops of 2% lead acetate solution were 
added. Then, it was observed whether it develops 
yellow or orange colour which indicates the pres-
ence of flavonoids. 
Test for Terpenoids: Five milliliter of plant extract 
was mixed in 2 ml of chloroform followed by the 
careful addition of 3 ml concentrated (H2SO4). 
A layer of the eddish brown colouration formed at 
the interface indicates a positive result for the pres-
ence of terpenoids. 
Test for glycosides: Small amount of extract was 
disoolved in 1 ml water and sodium hydroxide 
solution was added. A yellow colour indicates the 
presence of glycosides.
Preliminary Acute Toxicity Test 
The acute toxicity median lethal dose (LD50) of 
the extract was estimated p.o. in Swiss albino mice 
following the 2008 Organization for Economic 
Co-operation and Development (OECD) guide-
line.22 Accordingly, a limit test was done at 
2000 mg/kg using a total of three mice with each 
mouse given the extract sequentially in 48 hr. The 
mice were carefully observed for a total of 15 days 
for any change in body weight (weekly), changes in 
skin and fur, lacrimation, salivation, diarrhea, leth-
argy, sleep, coma and death.
Grouping and Dosing of Animals
The mice were divided into negative control, pos-
itive control and three test groups of five animals 
each. The negative control received distilled water 
and the positive control received chloroquine 
(25  mg/kg) and the test groups received orally 
different doses of the 80% methanol leaf extract of 
R.chalepensis (100 mg/kg, 200 mg/kg and 400 mg/
kg body weight). These doses were selected accord-
ing to the result obtained from the acute toxicity 
test study.
Parasite Inoculation: The parasitized erythrocytes 
for the test were collected from an infected donor 
mouse with rising parasitaemia of 30%. The mice 
were sacrificed by head blow, and blood was col-
lected in a Petri dish with an anticoagulant (0.5% 
trisodium citrate) by severing the jugular vein. 
The blood was then diluted with physiological 
saline (0.9%) in proportion of 1:4. Each mouse was 
then inoculated with 0.2 mL of blood containing 
about 107 P. berghei infected erythrocytes on day 0 
through intra peritoneal route.23 
In vivo antiplasmodial test: Antimalarial activity 
screening of the crude extract of R.chalepensis was 
carried out using a 4-day suppressive standard 
test according to the method of Fidock. 20 After 
three hours of parasite inoculation, three test 
groups of mice were administered with 100, 200 
and 400 mg/kg of the crude extract. The negative 
control group mice were treated with 2 ml/100g 
of the vehicle (distilled water) and the positive 
control groups were treated with 25 mg/kg of 
chloroquine.23 
Determination of parasitaemia: On the fifth day 
(96  hrs post infection), a drop of blood was taken 
from tail snip of each mouse on frosted slide and 
smears were prepared, fixed with methanol and 
stained with 10% Giemsa solution at pH 7.2 for 
15 min. Then, five fields were randomly selected on 
each stained slide and examined under microscope 
with an oil immersion objective (×100 magnification 
power). The parasitaemia level was determined by 
counting the number of parasitized erythrocytes on 
randomly selected fields of the slide. Parasite suppres-
sion was calculated by using the following formula. 
Where by: % Parasitaemia= (Number of parasit-
ized RBC/ Total number of RBC count) × 100 
Determination of survival time and mean 
body weight 
The survival-time (in days) was recorded for all 
mice and the mean survival time of the extract 
treated groups was compared to the vehicle treated 
group. Bodyweight of each mouse prior to treat-
ment initiation and at the end of treatment (96 hrs 
post infection) were taken to see if there was body-
weight change as an adverse effect of the extract 
treatment. 
Statistical analysis: Data were analyzed using 
Windows SPSS Version 20. One-way analysis of 
variance (ANOVA) followed by Tukey’s HSD post-
hoc test was used to compare parasitemia among 
the groups. Paired t-test was also used to compare 
initial and final results of the bodyweight following 
extract treatment. Results obtained from the study 
were presented as mean plus or minus standard 
error of the mean (M ± SEM). A P value < 0.05 was 
considered as statistically significant. 
% parasite 
suppression =
mean parasitemia 
in negative control –
mean parasitemia 
in study group
× 100
mean parasitemia in negative control
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Ethical clearance: The animals were handled 
according to the international animal care and 
welfare guideline19 and an ethical clearance was 
obtained from the ethical review committee of 
the department of Pharmacology, University of 
Gondar.
RESULTS
This study explored the phytochemical contents, 
the acute toxicity as well as blood schizonticidal 
activity against P.berghei of R.chalepensis.
Percentage yield: The 80% methanol leaf extract 
of Ruta chalepensis was a dark green, hygroscopic 
semi-solid at room temperature with a percentage 
yield of 20.93% w/w. 
Phytochemical screening of R.chalepensis: 
Preliminary phytochemical screening of the 80% 
methanol leaf extract of R.chalepensis revealed the 
presence of alkaloids, phenolic compounds, sapo-
nins, flavonoids, terpenoids and cardiac glycosides. 
Table 1.
Acute oral toxicity of R.chalepensis: Only lethargy 
that lasts 45 minutes was observed in the mice 
after oral administration of 2000 mg/kg extract of 
R.chalepensis. The oral LD50 of the extract was thus 
greater than 2000 mg/kg. The mice were physically 
active and fed and drunk as that of the control groups 
administered with the vehicle (distilled water) within 
the 15 days observation period. All the mice used in 
the acute toxicity test gained a weekly bodyweight 
increment in the 15 days observation period. 
In vivo antimalarial activity of R.chalepensis
Outcome of the four-day suppressive test was 
expressed as percent of reduction of parasitaemia 
level relative to the negative control mice and is 
summarized in Table 2. The extract demonstrated 
antiplasmodial activity at all test doses but the 
reduction in parasitaemia level was inversely related 
to the dose. Thus the highest effect observed was for 
the 100 mg/kg extract dose (46.01%) and it reduced 
parasitaemia to significant level (p<0.01). the par-
asite suppression effect progressively decreased as 
the dose increased to 200 mg/kg and 400 mg/kg.
Effect of R. chalepensis on survival time of 
mice 
As shown in Table 3, the mean survival time (days) 
of the 100 mg/kg extract treated group was 9.83 ± 
0.33 and this significantly (p=0.032) differ from the 
vehicle treated group. However despite an increase 
in survival, the observed effect is not significantly 
different for the two higher doses.
Effect of R. chalepensis on body weight of 
mice 
As can be seen in Table 4, all extract treated groups 
as well as control groups have lost body weight 
following their treatment. This was highest (8.2%) 
for the 400 mg/kg extract treated group. Pair wise 
 comparison of the bodyweight before and after 
completion of the treatment revealed that the 
200  mg/kg and 400 mg/kg dose extract treated 
groups lost their body weight significantly (P<0.05) 
compared to the vehicle treated group. 
DISCUSSION
The present study was driven by an ethnobotanic 
study that reported antimalarial and anti fever 
uses of R.chalepensis,14 experimental study which 
reported anti-oxidant as well as anti-inflammatory 
activities,17 and undocumented claims by the local 
Table 1  Results of phytochemical screening of methanolic seed 
extract of R. chalepensis 
Serial number Tests Extract
1 phenols +
2 Saponins +
3 Alkaloids +
4 Flavonoids +
6 Terpenoids +
7 Glycosides +
(+) = Present
Table 2  Effect of 80% methanol crude extract of R. chalepensis on 
parasitaemia level of P. berghei infected Swiss albino mice
Treatment % parasitaemia at D4
% parasite 
Suppression 
Distilled water 2 ml/100g 55.42 ± 0.72 0.00
RC 100 mg/kg 29.92 ± 0.94 (P= 0.000) 46.01
RC 200 mg/kg  40.75 ± 1.49 (p= 0.023) 26.47
RC 400 mg/kg 50.25 ± 1.42 (p= 0.081) 9.33
Chloroquine 25 mg/kg 1.47 ± 0.66 (p=0.000) 97.35
Values are expressed as Mean ± SEM; n = 5; RC= Ruta chalepensis; D4= day four;
Table 3  Mean survival time of infected mice after treatment with 
80% methanol crude extract of R. chalepensis
Treatment mean Survival time ±SEM (day)
Distilled water 2 ml/100g 7.67 + 0.33
RC 100 mg/kg 9.83 + 0.33 (p=0.032)
RC 200 mg/kg 9.07 + 0.29 (p=0.081)
RC 400 mg/kg 8.33 + 0.33 (p=0.552)
Chloroquine 25 mg/kg 28.00 + 0.00 (p=0.000)
Values are expressed as Mean ± SEM; n = 5; RC= Ruta chalepensis; D4= day four
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people for the use of the plant against malaria. It 
was done to evaluate the antiplasmodial activity, to 
determine phytochemicals present and the acute 
oral toxicity of the plant. Such studies are gener-
ally supported by the WHO. This organization has 
encouraged the use of validated, low-cost tradi-
tional antimalarial preparations to treat fever and 
malaria. Research priorities include the assessment 
of efficacy and safety of new herbal antimalarials 
and standardization of extracts.24 
In this study, a hydroalcoholic (80% methanol) 
solvent was used for extraction as such solvent is 
good for extracting a wide variety of polar and 
moderately polar compounds.25 The study con-
firmed the presence of alkaloids, polyphenols, 
flavonoids, saponins, cardiac glycosides and ter-
penoids in the extract of R.chalepensis which is 
consistent with previous studies.15,16 The oral LD50 
was determined to be greater than 2000 mg/kg 
and is in line with a previous study where the oral 
LD50 is reported to be greater than 5000 mg/kg.16 
The only observed toxicity was rapid and brief 
duration of lethargy which strengthens the CNS 
depressant activity of the plant reported so far.16 
Thus, R.chalepensis lacks significant acute toxicity 
in mice at the dose levels used in this experiment. 
However further studies such as sub-acute toxicity 
needs to be done. Rodent model with P.berghei was 
used for this study because the model is widely 
accepted. The 4-day suppressive test is a stan-
dard test commonly used for antimalarial activity 
screening and the determination of percent inhibi-
tion of parasitaemia is the most reliable parameter. 
This method has become popular during scientific 
evaluation of potential phytomedicines for early 
investigations of the in vivo efficacy of an antima-
larial activity.23 In the four day suppressive test, 
treatment with 100 mg/kg and 200 mg/kg doses 
of R.chalepensis extract reduced the parasite load 
in the mice suggesting activity against the blood 
stage of the parasite. Thus the plant is considered 
active in the screening test and can be candidate for 
doing further studies. A higher than 10% parasite 
suppression (i.e. a mean group parasitemia level 
of less than or equal to 90% of that of the vehicle 
treated control group) usually indicates that the 
test compound is active in standard screening 
studies.26
Antiplasmodial activity was demonstrated at 
all test doses but magnitude of effect was inversely 
related to the dose. The observed highest effect at 
the smallest dose seems consistent with the tradi-
tional claim that low dose (8-10 fresh leaves) has 
been chewed without swallowing twice a day for 
5 days in the treatment of malaria.14 The progres-
sive decrease in parasite suppression activity of the 
extract with an increase in the dose may be due to 
its crude nature so that with higher doses there may 
be negative interactions among the phytochemicals 
present in the extract. The same reason (i.e. crude 
nature) may explain why the maximal effect of the 
extract was still very much lower compared to the 
standard drug, chloroquine. 
As the follow up on survival of the mice revealed, 
the symptoms of the disease on the extract treated 
groups were becoming worse and eventually death 
occurred due to a rise in parasitemia while chloro-
quine treated groups were alive by the end of the 
month following the treatment. The rise in para-
sitemia of extract treated mice might suggest that 
the actions of the extract were small (insufficient) 
and/or were short-lived due to rapid metabolism or 
elimination.27 
The potential for antimalarial drug develop-
ment of several phytochemicals such as alkaloids, 
terpenoids, flavonoids, coumarins, phenolics, poly-
acetylenes, xanthones, quinones, steroids and lig-
nans was documented in previous studies.28,29 Thus 
one or more of the phytochemicals demonstrated 
in the present study may be responsible for the 
observed antiplamodial activity of R.chalepensis.
A significant increase in survival time (days) 
was demonstrated only with the 100 mg/kg extract 
treatment and this parallels its highest antiplasmo-
dial activity in the study. Therefore at this dose, the 
disease progression was delayed better than the two 
higher doses. 
Moreover, extract treatment protected the mice 
from losing weight which is parallel to the effect 
observed in antimalarial activity i.e. highest and 
Table 4 Body weight changes of the mice after administration of the hydroalcoholic extract of R. chalepensis
Mice group
Mean Bodyweight(g)  
at D0 ±SEM
Mean Bodyweight(g)  
at D4 ±SEM % change P value
Distilled water 2 ml/100g 24.01 + 0.58 23.90 + 0.44 -0.46 0.36
RC 100 mg/kg 23.68 + 0.90 25.47 + 0.97 7.03 0.04
RC 200 mg/kg 22.53 + 1.33 24.01 + 0.62 6.16 0.083
RC 400 mg/kg 21.37 + 1.11 22.47 + 0.64 4.9 0.13
Chloroquine 25 mg/kg 20.93 + 0.27 22.80 + 0.49 8.2 0.014
Values are expressed as Mean ± SEM; n = 5; RC= Ruta chalepensis; D0 (the first 24 hr post infection); D4= day four
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significant (p=0.04) weight gain was noted for the 
100 mg/kg dose. This protection from weight loss is 
explained by the antimarial effect of the plant since 
body weight loss is a feature expected in rodents 
infected with malaria parasite.30 The protection 
from weight loss, added to the decrease in mean 
parasitemia, is also suggestive for antimalarial effect 
of the extract. 
CONCLUSIONS
Ruta chalepensis therefore has antimalarial activity 
and no significant acute toxic effect when taken 
orally. The study validates its traditional use in 
malaria treatment. We suggest further investigation 
on this potential plant in the search for a novel anti-
malaria drug. 
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